Generate a tailored SOP for Dr. Ali Roghanian. Improve your application with a focused, well-structured draft.
Dr. Ali Roghanian is an associate professor at the University of Southampton specializing in cancer immunotherapy. His research focuses on the fundamental interactions between the immune system and malignant cells, aiming to enhance the efficacy of treatments for various cancer types, particularly the hard-to-treat cancers. Dr. Roghanian's group employs innovative technologies and advanced preclinical models to investigate mechanisms of tumor-mediated immunosuppression and the application of targeted therapies. His work includes developing monoclonal antibodies and novel cellular therapies, such as chimeric antigen receptor (CAR) therapies, to counteract therapy resistance in patients. Dr. Roghanian collaborates closely with both the biotechnology and pharmaceutical sectors, as well as prominent academic institutions to translate basic research into effective therapeutics. Throughout his career, he has been awarded fellowships and prizes for his contributions to cancer research, including the Blood Cancer UK Visiting Fellowship. He is also actively involved in teaching various courses related to cancer biology and immunology.
University of Southampton • Southampton, England
Leading research group focused on cancer immunotherapy, developing innovative treatment strategies and conducting advanced research.